Evidence map›Paper›PMID 41540694›Full record

ArticleNan fang yi ke da xue xue bao = Journal of Southern Medical University2026

[

Zhaoyong Li, Fenghua Zhou, Xiaomin Sun, Huashan Zhao, Yao Jin, Peikun He, Yuhua Jia

Abstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zhaoyong LiSchool of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China.
Fenghua ZhouSchool of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China.
Xiaomin SunSchool of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China.
Huashan ZhaoSchool of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China.
Yao JinSchool of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China.
Peikun HeSchool of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China.
Yuhua JiaSchool of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China.

Funding

National Natural Science Foundation of China 82174299 and 82574757
6 · The paper itself

Abstract

objectivesTo explore the therapeutic mechanism of

methodsThe active components and disease targets of JZQBR were screened using TCMSP and GeneCards databases, followed by protein-protein interaction analysis and GO and KEGG enrichment analyses. In the animal experiments,

resultsNetwork pharmacology identified 65 potential targets, with quercetin, kaempferol, and luteolin as the core components and IL-6, IL-1β, and TNF‑α as the key targets. The targets were enriched mainly in the pathways involving inflammatory responses and diabetic complications. In the

conclusionsJZQBR improves T2DM complicated with hyperlipidemia possibly by multi-target regulation of the inflammation-metabolism network.

Indexed as

Diabetes Mellitus, Type 2Drugs, Chinese HerbalHyperlipidemiasAnimalsHumansInflammationMaleMiceNetwork PharmacologyDrugs, Chinese HerbaljiangzhihyperlipidemiaJiangzhi Quban recipenetwork pharmacologytype 2 diabetes mellitus

Identifiers

PMID41540694
PMCPMC12809034

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.